Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 3
1997 2
1998 1
2000 3
2001 3
2002 9
2003 7
2004 2
2005 20
2006 18
2007 15
2008 16
2009 10
2010 18
2011 12
2012 16
2013 17
2014 28
2015 26
2016 29
2017 34
2018 28
2019 27
2020 53
2021 57
2022 53
Text availability
Article attribute
Article type
Publication date

Search Results

454 results
Results by year
Filters applied: . Clear all
Page 1
Update on the use of immunoglobulin in human disease: A review of evidence.
Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, El-Gamal Y, Harville TO, Hossny E, Mazer B, Nelson R, Secord E, Jordan SC, Stiehm ER, Vo AA, Ballow M. Perez EE, et al. Among authors: vo aa. J Allergy Clin Immunol. 2017 Mar;139(3S):S1-S46. doi: 10.1016/j.jaci.2016.09.023. Epub 2016 Dec 29. J Allergy Clin Immunol. 2017. PMID: 28041678 Review.
Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes).
Jordan SC, Legendre C, Desai NM, Lorant T, Bengtsson M, Lonze BE, Vo AA, Runström A, Laxmyr L, Sjöholm K, Schiött Å, Sonesson E, Wood K, Winstedt L, Kjellman C, Montgomery RA. Jordan SC, et al. Among authors: vo aa. Transplantation. 2021 Aug 1;105(8):1808-1817. doi: 10.1097/TP.0000000000003496. Transplantation. 2021. PMID: 33093408 Free PMC article. Clinical Trial.
Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients.
Kjellman C, Maldonado AQ, Sjöholm K, Lonze BE, Montgomery RA, Runström A, Lorant T, Desai NM, Legendre C, Lundgren T, von Zur Mühlen B, Vo AA, Olsson H, Jordan SC. Kjellman C, et al. Among authors: vo aa. Am J Transplant. 2021 Dec;21(12):3907-3918. doi: 10.1111/ajt.16754. Epub 2021 Jul 19. Am J Transplant. 2021. PMID: 34236770 Free PMC article. Clinical Trial.
Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer.
Becker LM, O'Connell JT, Vo AP, Cain MP, Tampe D, Bizarro L, Sugimoto H, McGow AK, Asara JM, Lovisa S, McAndrews KM, Zielinski R, Lorenzi PL, Zeisberg M, Raza S, LeBleu VS, Kalluri R. Becker LM, et al. Among authors: vo ap. Cell Rep. 2020 Jun 2;31(9):107701. doi: 10.1016/j.celrep.2020.107701. Cell Rep. 2020. PMID: 32492417 Free PMC article.
IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
Jordan SC, Lorant T, Choi J, Kjellman C, Winstedt L, Bengtsson M, Zhang X, Eich T, Toyoda M, Eriksson BM, Ge S, Peng A, Järnum S, Wood KJ, Lundgren T, Wennberg L, Bäckman L, Larsson E, Villicana R, Kahwaji J, Louie S, Kang A, Haas M, Nast C, Vo A, Tufveson G. Jordan SC, et al. Among authors: vo a. N Engl J Med. 2017 Aug 3;377(5):442-453. doi: 10.1056/NEJMoa1612567. N Engl J Med. 2017. PMID: 28767349 Free article. Clinical Trial.
Vo AX, Auffenberg GB. Vo AX, et al. Urology. 2021 Jul;153:138. doi: 10.1016/j.urology.2020.10.081. Urology. 2021. PMID: 34311907 No abstract available.
454 results